FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model

por Deuschle, Ulrich, Schüler, Julia, Schulz, Andreas, Schlüter, Thomas, Kinzel, Olaf, Abel, Ulrich, Kremoser, Claus
Publicado 2012

Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534

por Xue, Xiaohua, De Leon-Tabaldo, Aimee, Luna-Roman, Rosa, Castro, Glenda, Albers, Michael, Schoetens, Freddy, DePrimo, Samuel, Devineni, Damayanthi, Wilde, Thomas, Goldberg, Steve, Kinzel, Olaf, Hoffmann, Thomas, Fourie, Anne M., Thurmond, Robin L.
Publicado 2021

Author Correction: Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534

por Xue, Xiaohua, De Leon-Tabaldo, Aimee, Luna-Roman, Rosa, Castro, Glenda, Albers, Michael, Schoetens, Freddy, DePrimo, Samuel, Devineni, Damayanthi, Wilde, Thomas, Goldberg, Steve, Kinzel, Olaf, Hoffmann, Thomas, Fourie, Anne M., Thurmond, Robin L.
Publicado 2022